FindTrial
Sign In

Follow-up and management of idiopathic inflammatory myopathy: a prospective cohort study

Study on accurate diagnosis and individualized treatment of idiopathic inflammatory myopathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063070
Enrollment
Unknown
Registered
2022-08-30
Start date
2022-08-30
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic inflammatory myopathy

Interventions

None listed

Sponsors

Shandong University Qilu Hospital (Qingdao)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed with idiopathic inflammatory myopathy signed informed consent before enrollment.

Exclusion criteria

Exclusion criteria: Patients who did not comply with the follow-up plan could not complete the follow-up.

Design outcomes

Primary

MeasureTime frame
muscle pathological biopsy;myositis antibody;muscle enzyme;electromyography, EMG;electrocardiogram, ECG;Muscle MRI;Strength;—

Countries

China

Contacts

Public ContactChuanzhu Yan

Shandong University Qilu Hospital (Qingdao)

chuanzhuyan@163.com+86 18561811888

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026